TCR-Guided Therapies to Match Individual Patient Needs
Time: 11:00 am
day: Day 2
Details:
• We develop three TCR-guided modalities, TCR-T cells, TCR-NK cells, and TCR-TCEs, based on our 3S TCR technologies.
• We assemble a library of 3S TCRs of different antigen specificity and HLA restriction to meet needs for more patients worldwide.
• Our E2E Platform adds innovative solutions for improved development, safety and efficacy of our TCR-guided immunotherapies.
